search
antibiotics
Trends
- 1New Blood Test Distinguishes Bacterial and Viral Infections in Newborns▼Blood Test Differentiates Bacterial and Viral Infections in Newborns
A new blood test can differentiate between bacterial and viral infections in newborns, according to a report by Inside Precision Medicine. The development could help doctors decide when antibiotics are truly needed in infants, where diagnosing infection has long been difficult and often leads to precautionary antibiotic use. The finding is drawing attention in medical and precision diagnostics circles.
- 2University of Kansas wins $5.8 million NIH grant against antibiotic resistance▼University of Kansas Lands $5.8 Million NIH Grant to Fight Antibiotic Resistance
The University of Kansas has been awarded a $5.8 million grant from the National Institutes of Health to support research into combating antibiotic resistance. The funding will back efforts to develop new approaches as drug-resistant bacteria remain a growing global health threat, with the university positioned among institutions receiving major federal support for this work.
- 3Blood test distinguishes bacterial from viral infections in newborns▼Blood test shows whether newborns with fever have bacterial or viral infection
Researchers have developed a blood test that can show whether a newborn with a fever has a bacterial or a viral infection. The advance could help doctors decide quickly whether infants need antibiotics, reducing unnecessary treatment and speeding up care for babies with serious bacterial illness. Medical outlets are reporting on the test's potential to improve diagnosis in newborns, a group in whom infections are hard to distinguish and can become dangerous fast.
- 4New test could distinguish bacterial from viral infections in feverish babies●Feverish babies in hospital are often assumed to have a serious bacterial infection and are treated with antibiotics. Bu
Feverish babies admitted to hospital are often assumed to have a serious bacterial infection and are treated with antibiotics as a precaution. A new test that gauges whether an infection is bacterial or viral could reduce unnecessary antibiotic use in infants, helping doctors avoid overprescription and supporting efforts against antimicrobial resistance.
- 5Colombian Mosquitoes and Sand Flies Carry Hidden Viruses and Resistance Genes▼Hidden Viral Worlds and Antibiotic Resistance Genes Found in Colombian Mosquitoes and Sand Flies
Researchers in Colombia have identified previously unknown viruses and antibiotic resistance genes in mosquitoes and sand flies, revealing that these disease-carrying insects host far more microbial life than expected. The findings suggest the insects could play a role in spreading antimicrobial resistance, adding a new dimension to concerns about mosquito-borne disease in the region.
- 6Brazilian Cerrado Plant Extract Revives Antibiotics Against Superbugs▼Brazilian Cerrado Plant Extract Restores Antibiotic Power Against Resistant Superbugs
Researchers report that an extract from a plant native to Brazil's Cerrado savanna can restore the effectiveness of antibiotics against drug-resistant bacteria. The finding suggests the extract works alongside existing drugs to overcome resistance mechanisms in so-called superbugs, offering a potential new lead in the fight against antimicrobial resistance, a growing global health threat.
- 7Plant-Based Nanoparticles Disarm MRSA Bacteria▼Plant-Powered Nanoparticles Strip MRSA of Its Adhesive Weapons
Researchers have developed plant-derived nanoparticles that can strip MRSA of the adhesive mechanisms the antibiotic-resistant bacterium uses to stick to cells and surfaces. By removing these adhesive weapons, the nanoparticles could make the superbug easier for the immune system to clear, offering a potential alternative approach to treating resistant infections without relying on traditional antibiotics.
- 8New PCR Test Detects Macrolide-Resistant Mycoplasma pneumoniae in Hours●Fluorescence PCR Test Spots Macrolide-Resistant Mycoplasma pneumoniae in Hours
A fluorescence-based PCR test has been developed that can identify macrolide-resistant Mycoplasma pneumoniae, the bacterium behind common respiratory infections, within hours rather than days. Rapid detection of resistance matters because macrolides are a first-line treatment, and resistant strains force clinicians to switch therapies. The test could help doctors choose effective antibiotics sooner and support surveillance of resistant mycoplasma strains.